Authors:
Lum, JJ
Pilon, AA
Sanchez-Dardon, J
Phenix, BN
Kim, JE
Mihowich, J
Jamison, K
Hawley-Foss, N
Lynch, DH
Badley, AD
Citation: Jj. Lum et al., Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2L, J VIROLOGY, 75(22), 2001, pp. 11128-11136
Citation: Dh. Dockrell et al., Immune-mediated phagocytosis and killing of Streptococcus pneumoniae are associated with direct and bystander macrophage apoptosis, J INFEC DIS, 184(6), 2001, pp. 713-722
Authors:
Daro, E
Pulendran, N
Brasel, K
Teepe, M
Pettit, D
Lynch, DH
Vremec, D
Robb, L
Shortman, K
McKenna, HJ
Maliszewski, CR
Maraskovsky, E
Citation: E. Daro et al., Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: A comparative analysis with Flt3 ligand, J IMMUNOL, 165(1), 2000, pp. 49-58
Authors:
McKenna, HJ
Stocking, KL
Miller, RE
Brasel, K
De Smedt, T
Maraskovsky, E
Maliszewski, CR
Lynch, DH
Smith, J
Pulendran, B
Roux, ER
Teepe, M
Lyman, SD
Peschon, JJ
Citation: Hj. Mckenna et al., Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells, BLOOD, 95(11), 2000, pp. 3489-3497
Authors:
Badley, AD
Parato, K
Cameron, DW
Kravcik, S
Phenix, BN
Ashby, D
Kumar, A
Lynch, DH
Tschopp, J
Angel, JB
Citation: Ad. Badley et al., Dynamic correlation of apoptosis and immune activation during treatment ofHIV infection, CELL DEAT D, 6(5), 1999, pp. 420-432
Authors:
Walczak, H
Miller, RE
Ariail, K
Gliniak, B
Griffith, TS
Kubin, M
Chin, W
Jones, J
Woodward, A
Le, T
Smith, C
Smolak, P
Goodwin, RG
Rauch, CT
Schuh, JCL
Lynch, DH
Citation: H. Walczak et al., Tumoricidal activity of tumor necrosis factor related apoptosis-inducing ligand in vivo, NAT MED, 5(2), 1999, pp. 157-163
Authors:
Dockrell, DH
Badley, AD
Algeciras-Schimnich, A
Simpson, M
Schut, R
Lynch, DH
Paya, CV
Citation: Dh. Dockrell et al., Activation-induced CD4(+) T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4(+) T cell count, and HIV plasma viral copynumber, AIDS RES H, 15(17), 1999, pp. 1509-1518
Authors:
Josefsen, D
Myklebust, JH
Lynch, DH
Stokke, T
Blomhoff, HK
Smeland, EB
Citation: D. Josefsen et al., Fas ligand promotes cell survival of immature human bone marrow CD34(+)CD38(-) hematopoietic progenitor cells by suppressing apoptosis, EXP HEMATOL, 27(9), 1999, pp. 1451-1459
Authors:
Borges, L
Miller, RE
Jones, J
Ariail, K
Whitmore, J
Fanslow, W
Lynch, DH
Citation: L. Borges et al., Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand inthe induction of dendritic cells and generation of antitumor immunity in vivo, J IMMUNOL, 163(3), 1999, pp. 1289-1297
Authors:
Algeciras-Schimnich, A
Griffith, TS
Lynch, DH
Paya, CV
Citation: A. Algeciras-schimnich et al., Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis, J IMMUNOL, 162(9), 1999, pp. 5205-5211